Application

15275050 · Use Of Modulators Of CCR5 In The Treatment Of Cancer And Cancer Metastasis

Filed 2016-09-23 · Abandoned The official file ↗ · Art unit 1642 · Examiner Karl J Puttlitz Typical · CPC A61K 31/506 · NIH-DEITR · SEED IP LAW GROUP LLP/GENERAL FIRM (EMAIL)

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

18.0 mo

to disposition 66.4 mo

Statutes raised

102 103 112 DP

6 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.